rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2000-1-5
|
pubmed:abstractText |
Cancer patients frequently experience anemia as a consequence of myelosuppressive therapy or bone marrow invasion.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0732-183X
|
pubmed:author |
pubmed-author:BachelotTT,
pubmed-author:BironPP,
pubmed-author:BlayJ YJY,
pubmed-author:ChevreauCC,
pubmed-author:Le CesneAA,
pubmed-author:MaugardCC,
pubmed-author:MermetJJ,
pubmed-author:RavaudAA,
pubmed-author:Ray-CoquardII,
pubmed-author:RubinM SMS,
pubmed-author:SebbagDD
|
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2840-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10561360-Adolescent,
pubmed-meshheading:10561360-Adult,
pubmed-meshheading:10561360-Age Factors,
pubmed-meshheading:10561360-Aged,
pubmed-meshheading:10561360-Aged, 80 and over,
pubmed-meshheading:10561360-Analysis of Variance,
pubmed-meshheading:10561360-Anemia,
pubmed-meshheading:10561360-Antineoplastic Agents,
pubmed-meshheading:10561360-Cohort Studies,
pubmed-meshheading:10561360-Erythrocyte Transfusion,
pubmed-meshheading:10561360-Female,
pubmed-meshheading:10561360-Hemoglobin A,
pubmed-meshheading:10561360-Humans,
pubmed-meshheading:10561360-Logistic Models,
pubmed-meshheading:10561360-Male,
pubmed-meshheading:10561360-Middle Aged,
pubmed-meshheading:10561360-Neoplasms,
pubmed-meshheading:10561360-Probability,
pubmed-meshheading:10561360-Retrospective Studies,
pubmed-meshheading:10561360-Risk Factors,
pubmed-meshheading:10561360-Severity of Illness Index
|
pubmed:year |
1999
|
pubmed:articleTitle |
Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group.
|
pubmed:affiliation |
Centre Léon Bérard, Lyon, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|